---
schema_version: "secwatch.filing_event.v1"
accession: "0001162194-23-000055"
form_type: "8-K"
ticker: "LAB"
cik: "0001162194"
company_name: "STANDARD BIOTOOLS INC."
filed_at: "2023-08-08T23:59:59+00:00"
generated_at: "2026-06-12T00:45:56.953255+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Standard BioTools Q2 revenue up 47% to $27.7M; gross margins surge

## Summary
- Revenue $27.7M (+47% YoY); GAAP gross margin 49.2% vs 23.6% YoY.
- Non-GAAP gross margin 60.9% vs 40.2%; operating loss improved to ($17.4M) from ($38.6M).
- Non-GAAP operating expenses down 25% to $25.2M; net loss ($17.0M) vs ($63.5M).
- Non-GAAP adjusted EBITDA loss ($8.4M) vs ($26.2M); operating cash use down >70% to $8.5M.
- Cash and equivalents $143.1M; launched Hyperion XTi Imaging System.

## SEC filing metadata
- accession: 0001162194-23-000055
- form_type: 8-K
- ticker: LAB
- cik: 0001162194
- company_name: STANDARD BIOTOOLS INC.
- filed_at: 2023-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1162194/000116219423000055/0001162194-23-000055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1162194/000116219423000055/lab-20230808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001162194-23-000055
- JSON: https://secwatch.observer/filing/0001162194-23-000055.json
- Plain text: https://secwatch.observer/filing/0001162194-23-000055.txt

## Key facts
- Earnings Releases
  STANDARD BIOTOOLS INC. reported quarter ended June 30, 2023 results: revenue $27.7, net income ($17.0).
  - Period: quarter ended June 30, 2023
  - Revenue: $27.7
  - Net income: ($17.0)
  - Result: reported results
  source text: Selected Financial Results (Numbers in millions, except percentages) Quarter Ended June 30, 2023 Quarter Ended June 30, 2022 Revenue $27.7 $18.8 (a) Gross margin 49.2% 23.6% Non-GAAP gross margin 60.9% 40.2% Operating expenses $31.1 $43.0 Non-GAAP operating expenses $25.2 $33.8 Operating loss ($17.4) ($38.6) Net loss ($17.0) ($63.5)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1162194/000116219423000055/0001162194-23-000055-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.